NIH Launches New Childhood Cancer Genomics Program
Pediatric and young adult patients treated at facilities affiliated with the NCI-sponsored Children's Oncology Group gain new, broad access to tumor molecular profiling.
Castle Biosciences Working With NCI on SEER Registry Study of DecisionDx-Melanoma
A first data analysis has shown patients with DecisionDx-Melanoma testing had better overall survival rates than those who were not tested.
President Biden Jumpstarts Cancer Moonshot Initiative With Goal of Halving Death Rate
The renewal of the ambitious effort includes the reestablishment of direct White House leadership, with a cross-agency cabinet to drive progress in early detection and care equity.
DiaCarta to Explore XNA Clamp Tech for Low-Frequency Mutations Under NIH Collaboration
Working under a two-year cooperative R&D agreement, the firm will explore its platform for cancer and rare disease mutation detection and in situ cancer cell analyses.
Kephera Diagnostics Wins $2M NCI Grant to Complete Development of Liver Fluke Infection Test
Liver fluke can infect humans who consume raw or undercooked freshwater fish, and long-term infection is associated with a form of bile duct cancer.